AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Trial

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Linkoeping
💬

In plain words

What the trial is, and whether it could suit you

Background: Small bowel obstruction (SBO) is a surgical emergency where the normal continuous bowel movements are hindered and approximately 8000-9000 patients visit the emergency department every year in Sweden due to SBO. A minority of these have evidence of intestinal injury, warranting emergency surgery, while the majority (70-90%) will have an initial plan for non-operative management with a nasogastric tube (NGT), placed to alleviate gastric pressure, reduce pain and prevent complications like aspiration pneumonia. The effectiveness of NGT in patients with SBO to prevent complications is unclear, with current data from observational data indicating increased risk of pneumonia in patients treated with NGT. Objective: To assess whether deferring the placement of a NGT in subjects with small bowel obstruction and planned for non-operative management leads to lower rates of respiratory

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Small bowel obstruction diagnosed on Computer Tomography Exclusion Criteria: * Nasogastric Tube already places * Amyotrophic lateral sclerosis * Cerebral palsy * Dementia * Parkinson's disease * Multiple Sclerosis * Previous stroke with documented persistent dysphagia * Planned for urgent surgery * Acute Massive Gastric Dilatation * Gastric outlet obstruction * Fundoplicatio/Inability to vomit * Signs of pneumonia/pneumonitis on initial diagnostic CT
💊

What it tests

  • Nasogastric tube placement
📍

Where

3 sites
Linköping University Hospital
Linköping, Sweden
Motala Lasarett
Motala, Sweden
Värnamo Lasarett
Värnamo, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy